The Association between Proton Pump Inhibitors and the Effectiveness of CDK Inhibitors in HR+/HER- Advanced Breast Cancer Patients: A Systematic Review and Meta-Analysis

SIMPLE SUMMARY: Proton pump inhibitors (PPIs) are frequently used in many patients with advanced breast cancer who are being treated with cyclin-dependent kinase inhibitors. In this study, our aim was to determine if there is an association between the use of PPIs and the effectiveness of cyclin-dep...

Descripción completa

Detalles Bibliográficos
Autores principales: Chang, Yu-Cheng, Song, Junmin, Chang, Yu, Huang, Chin-Hsuan, Sudan, Aarushi, Chen, Pei-Chin, Chi, Kuan-Yu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Systematic Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10649865/
https://www.ncbi.nlm.nih.gov/pubmed/37958308
http://dx.doi.org/10.3390/cancers15215133

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10649865/
https://www.ncbi.nlm.nih.gov/pubmed/37958308
http://dx.doi.org/10.3390/cancers15215133

Ejemplares similares